Hyundai Bioscience Co. Ltd Strategic Asset Allocation Index
Hyundai Bioscience Co. Ltd strategic asset allocation index. Hyundai Bioscience Co. Ltd (048410) has a Strategic Asset Allocation Index of 6.0% as of September 2024. Strategic assets (PP&E of ₩2.64 Billion plus long-term investments of ₩-) total ₩2.64 Billion, measured against net assets of ₩43.74 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See debt-free asset ratio of Hyundai Bioscience Co. Ltd to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Hyundai Bioscience Co. Ltd (2002–2022)
Strategic asset allocation index of Hyundai Bioscience Co. Ltd from 2002 to 2022. This chart shows how Hyundai Bioscience Co. Ltd's Strategic Asset Allocation Index has evolved across 20 annual periods from 2002 to 2022. As of September 2024, the index stands at 6.0%, representing strategic assets of ₩2.64 Billion against net assets of ₩43.74 Billion KRW. Check 048410 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Hyundai Bioscience Co. Ltd Strategic Asset Allocation Index by Year (2002–2022)
Hyundai Bioscience Co. Ltd strategic asset allocation index by year from 2002 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Hyundai Bioscience Co. Ltd from 2002 to 2022, covering 20 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see 048410 market cap.
| Year | SAAI | Strategic Assets (KRW) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 10.9% | ₩6.38 Billion | ₩6.38 Billion | ₩- | ₩58.24 Billion | ▲ +1.1 pp |
| 2021 | 9.9% | ₩6.07 Billion | ₩6.07 Billion | ₩- | ₩61.57 Billion | ▼ -3.2 pp |
| 2020 | 13.0% | ₩6.67 Billion | ₩6.67 Billion | ₩- | ₩51.22 Billion | ▼ -6.5 pp |
| 2019 | 19.5% | ₩9.17 Billion | ₩7.20 Billion | ₩1.97 Billion | ₩46.99 Billion | ▼ -4.0 pp |
| 2018 | 23.5% | ₩9.53 Billion | ₩8.37 Billion | ₩1.16 Billion | ₩40.48 Billion | ▼ -8.9 pp |
| 2017 | 32.4% | ₩10.01 Billion | ₩9.44 Billion | ₩571.51 Million | ₩30.89 Billion | ▼ -27.2 pp |
| 2016 | 59.6% | ₩10.85 Billion | ₩10.08 Billion | ₩773.38 Million | ₩18.21 Billion | ▲ +35.1 pp |
| 2015 | 24.5% | ₩6.02 Billion | ₩5.42 Billion | ₩600.25 Million | ₩24.60 Billion | ▼ -3.6 pp |
| 2014 | 28.1% | ₩6.31 Billion | ₩5.71 Billion | ₩600.25 Million | ₩22.49 Billion | ▲ +1.9 pp |
| 2013 | 26.2% | ₩5.71 Billion | ₩5.71 Billion | ₩- | ₩21.80 Billion | ▼ -11.8 pp |
| 2012 | 37.9% | ₩7.17 Billion | ₩7.17 Billion | ₩- | ₩18.90 Billion | ▲ +1.6 pp |
| 2011 | 36.3% | ₩5.15 Billion | ₩5.15 Billion | ₩- | ₩14.17 Billion | ▲ +15.7 pp |
| 2010 | 20.6% | ₩6.60 Billion | ₩6.60 Billion | ₩- | ₩32.08 Billion | ▲ +1.0 pp |
| 2009 | 19.5% | ₩7.68 Billion | ₩7.68 Billion | ₩- | ₩39.30 Billion | ▲ +5.9 pp |
| 2008 | 13.6% | ₩6.87 Billion | ₩6.87 Billion | ₩- | ₩50.36 Billion | ▲ +5.7 pp |
| 2007 | 8.0% | ₩4.65 Billion | ₩4.65 Billion | ₩- | ₩58.24 Billion | ▼ -35.5 pp |
| 2005 | 43.5% | ₩17.10 Billion | ₩17.10 Billion | ₩- | ₩39.33 Billion | ▲ +11.8 pp |
| 2004 | 31.7% | ₩19.33 Billion | ₩19.33 Billion | ₩- | ₩60.94 Billion | ▲ +5.0 pp |
| 2003 | 26.8% | ₩18.30 Billion | ₩18.30 Billion | ₩- | ₩68.34 Billion | ▼ -3.3 pp |
| 2002 | 30.1% | ₩19.26 Billion | ₩19.26 Billion | ₩- | ₩64.08 Billion | — |